Literature DB >> 8481550

Taurine prevents galactose-induced cataracts.

J I Malone1, S A Benford, J Malone.   

Abstract

Intact lenses from New Zealand white rabbits were incubated in tissue culture media containing either 5 mM glucose or 5 mM glucose plus 30 mM galactose. The standard media did not contain taurine. Lenses were also cultured in a third medium containing 30 mM galactose plus 0.2 mM taurine. The frequency of cataract formation was evaluated as a function of the culture media. One lens (1/10), in media containing 5 mM glucose, developed a lenticular opacification during a 72-h incubation. Lenses (12/15) incubated in 30 mM galactose, without taurine, developed cataracts; fewer lenses (2/13) exposed to 30 mM galactose plus 0.2 mM taurine developed cataracts (p < 0.005). Galactose cataracts have been associated with lens edema attributed to the osmotic stress of tissue polyol (galactitol) accumulation. The water content of the noncataractous and cataractous lenses in this experiment did not differ. Lens edema, therefore, was not thought to be important in cataract pathogenesis. Taurine, an organic osmolyte was lower (5.1 +/- 1.5 mumol/g protein) in cataractous lenses than in control lenses (10.0 +/- 1.0 mumol/g protein). Malondialdehyde, an indicator of lipid peroxidation, was higher (36.6 +/- 5.0 mumol/g protein) in lens-containing opacifications than in noncataractous lenses (10.1 +/- 1.9 mumol/gm protein) (p < 0.01). The levels of malondialdehyde suggest that lipid peroxidation was increased in the process of sugar cataractogenesis. The malondialdehyde content of all the lenses correlated inversely (r = -0.53, p < 0.01) with the coincident lens taurine levels. Taurine appears to protect the lens against the development of sugar cataracts; its inverse relationship with lens malondialdehyde suggests this is an antioxidant effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481550     DOI: 10.1016/1056-8727(93)90023-r

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

1.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

3.  Prevention of lens protein glycation by taurine.

Authors:  P S Devamanoharan; A H Ali; S D Varma
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

4.  Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

5.  Investigation of the Protective Effects of Taurine against Alloxan-Induced Diabetic Retinal Changes via Electroretinogram and Retinal Histology with New Zealand White Rabbits.

Authors:  Samuel Tung-Hsing Chiang; Shang-Min Yeh; Yi-Chen Chen; Shiun-Long Lin; Jung-Kai Tseng
Journal:  Int J Endocrinol       Date:  2014-09-14       Impact factor: 3.257

6.  Cataracts and strabismus associated with hand rearing using artificial milk formulas in Bengal tiger (Panthera tigris spp tigris) cubs.

Authors:  Rogério Ribas Lange; Leandro Lima; Erika Frühvald; Vera Sônia Nunes da Silva; Aparecida Sônia de Souza; Fabiano Montiani-Ferreira
Journal:  Open Vet J       Date:  2017-01-31

7.  Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.

Authors:  Igor Iezhitsa; Renu Agarwal; Sarah Diyana Bt Saad; Fatin Kamilah Bt Zakaria; Puneet Agarwal; Anna Krasilnikova; Thuhairah Hasrah Abdul Rahman; Khairul Nizam Bin Rozali; Alexander Spasov; Alexander Ozerov; Renad Alyautdin; Nafeeza Mohd Ismail
Journal:  Mol Vis       Date:  2016-07-10       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.